Cargando…
The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
PURPOSE: The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is a method for assessing the likelihood that a patient’s muscle symptoms (e.g., myalgia or myopathy) were caused or worsened by statin use. The objectives of this study were to prepare the SAMS-CI for clinical use, estimate its...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427100/ https://www.ncbi.nlm.nih.gov/pubmed/28421332 http://dx.doi.org/10.1007/s10557-017-6723-4 |
_version_ | 1783235600426467328 |
---|---|
author | Rosenson, Robert S Miller, Kate Bayliss, Martha Sanchez, Robert J Baccara-Dinet, Marie T Chibedi-De-Roche, Daniela Taylor, Beth Khan, Irfan Manvelian, Garen White, Michelle Jacobson, Terry A. |
author_facet | Rosenson, Robert S Miller, Kate Bayliss, Martha Sanchez, Robert J Baccara-Dinet, Marie T Chibedi-De-Roche, Daniela Taylor, Beth Khan, Irfan Manvelian, Garen White, Michelle Jacobson, Terry A. |
author_sort | Rosenson, Robert S |
collection | PubMed |
description | PURPOSE: The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is a method for assessing the likelihood that a patient’s muscle symptoms (e.g., myalgia or myopathy) were caused or worsened by statin use. The objectives of this study were to prepare the SAMS-CI for clinical use, estimate its inter-rater reliability, and collect feedback from physicians on its practical application. METHODS: For content validity, we conducted structured in-depth interviews with its original authors as well as with a panel of independent physicians. Estimation of inter-rater reliability involved an analysis of 30 written clinical cases which were scored by a sample of physicians. A separate group of physicians provided feedback on the clinical use of the SAMS-CI and its potential utility in practice. RESULTS: Qualitative interviews with providers supported the content validity of the SAMS-CI. Feedback on the clinical use of the SAMS-CI included several perceived benefits (such as brevity, clear wording, and simple scoring process) and some possible concerns (workflow issues and applicability in primary care). The inter-rater reliability of the SAMS-CI was estimated to be 0.77 (confidence interval 0.66–0.85), indicating high concordance between raters. With additional provider feedback, a revised SAMS-CI instrument was created suitable for further testing, both in the clinical setting and in prospective validation studies. CONCLUSIONS: With standardized questions, vetted language, easily interpreted scores, and demonstrated reliability, the SAMS aims to estimate the likelihood that a patient’s muscle symptoms were attributable to statins. The SAMS-CI may support better detection of statin-associated muscle symptoms in clinical practice, optimize treatment for patients experiencing muscle symptoms, and provide a useful tool for further clinical research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10557-017-6723-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5427100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-54271002017-05-26 The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability Rosenson, Robert S Miller, Kate Bayliss, Martha Sanchez, Robert J Baccara-Dinet, Marie T Chibedi-De-Roche, Daniela Taylor, Beth Khan, Irfan Manvelian, Garen White, Michelle Jacobson, Terry A. Cardiovasc Drugs Ther Original Article PURPOSE: The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is a method for assessing the likelihood that a patient’s muscle symptoms (e.g., myalgia or myopathy) were caused or worsened by statin use. The objectives of this study were to prepare the SAMS-CI for clinical use, estimate its inter-rater reliability, and collect feedback from physicians on its practical application. METHODS: For content validity, we conducted structured in-depth interviews with its original authors as well as with a panel of independent physicians. Estimation of inter-rater reliability involved an analysis of 30 written clinical cases which were scored by a sample of physicians. A separate group of physicians provided feedback on the clinical use of the SAMS-CI and its potential utility in practice. RESULTS: Qualitative interviews with providers supported the content validity of the SAMS-CI. Feedback on the clinical use of the SAMS-CI included several perceived benefits (such as brevity, clear wording, and simple scoring process) and some possible concerns (workflow issues and applicability in primary care). The inter-rater reliability of the SAMS-CI was estimated to be 0.77 (confidence interval 0.66–0.85), indicating high concordance between raters. With additional provider feedback, a revised SAMS-CI instrument was created suitable for further testing, both in the clinical setting and in prospective validation studies. CONCLUSIONS: With standardized questions, vetted language, easily interpreted scores, and demonstrated reliability, the SAMS aims to estimate the likelihood that a patient’s muscle symptoms were attributable to statins. The SAMS-CI may support better detection of statin-associated muscle symptoms in clinical practice, optimize treatment for patients experiencing muscle symptoms, and provide a useful tool for further clinical research. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10557-017-6723-4) contains supplementary material, which is available to authorized users. Springer US 2017-04-18 2017 /pmc/articles/PMC5427100/ /pubmed/28421332 http://dx.doi.org/10.1007/s10557-017-6723-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Rosenson, Robert S Miller, Kate Bayliss, Martha Sanchez, Robert J Baccara-Dinet, Marie T Chibedi-De-Roche, Daniela Taylor, Beth Khan, Irfan Manvelian, Garen White, Michelle Jacobson, Terry A. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability |
title | The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability |
title_full | The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability |
title_fullStr | The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability |
title_full_unstemmed | The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability |
title_short | The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability |
title_sort | statin-associated muscle symptom clinical index (sams-ci): revision for clinical use, content validation, and inter-rater reliability |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427100/ https://www.ncbi.nlm.nih.gov/pubmed/28421332 http://dx.doi.org/10.1007/s10557-017-6723-4 |
work_keys_str_mv | AT rosensonroberts thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT millerkate thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT baylissmartha thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT sanchezrobertj thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT baccaradinetmariet thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT chibediderochedaniela thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT taylorbeth thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT khanirfan thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT manveliangaren thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT whitemichelle thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT jacobsonterrya thestatinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT rosensonroberts statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT millerkate statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT baylissmartha statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT sanchezrobertj statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT baccaradinetmariet statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT chibediderochedaniela statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT taylorbeth statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT khanirfan statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT manveliangaren statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT whitemichelle statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability AT jacobsonterrya statinassociatedmusclesymptomclinicalindexsamscirevisionforclinicalusecontentvalidationandinterraterreliability |